Inhibition of lysyl oxidase (LOX) and cyclooxygenase (COX) activity by epigallocatechin-3-gallate (abbreviated as EGCG), epigallocatechin (EGC for short) and epicatechin-3-gallate (ECG), aside from modulating arachidonic acid metabolism, which importantly impacts cell growth, proliferation, tumor invasion and inflammation [81,82]. The gene discussed is LOX; the disease is neoplasm.